SEMA6A and neoplasm: For example, recent publications have identified mTOR signaling and the SEMA6A/RHOA/YAP axis as off-target mechanisms in BRAFi-associated tumor-protective effects of fibroblasts in the TME (Seip et al, 2016; Loria et al, 2022).